期刊文献+

肾上腺髓质素和脑钠肽在充血性心力衰竭中的对比研究

A comparative study on the roles of adrenomedullin and brain natriuretic peptide in congestive heart failure
下载PDF
导出
摘要 目的观察充血性心力衰竭(CHF)患者肾上腺髓质素(ADM)和脑钠肽(BNP)的水平变化,比较两者在CHF中的诊断价值及其灵敏度和特异度。方法CHF组共72例,其中冠心病陈旧性心肌梗死和缺血性心肌病20例,原发性高血压16例,以瓣膜关闭不全为主的风湿性心脏病18例,扩张型心肌病18例。根据NYHA心功能分级标准将CHF组又分为心功能Ⅱ级组20例、Ⅲ级组22例、Ⅳ级组30例。又按射血分数(EF)将CHF组分为EF<40%组(40例)和≥40%组(32例)。对照组45例,为非CHF患者,其中冠心病心绞痛24例,原发性高血压21例。分别用放射免疫法和酶标免疫法测定ADM和BNP的浓度,用心脏彩色多普勒超声心动图测定左室射血分数(LVEF)和左室舒张末内径(LVED)。结果CHF组总体BNP水平较非CHF组显著升高(P<0.05);ADM在CHF组较非CHF组有增高趋势,但两者比较差异无统计学意义。BNP诊断CHF的ROC曲线下面积为0.82,灵敏度和特异度明显优于ADM(P<0.01)。BNP与病因无相关。ADM和BNP与左室射血分数呈显著负相关(P<0.05)。ADM和BNP在NYHA心功能Ⅲ级组较Ⅱ级组显著升高(P<0.05);但心功能Ⅳ级组较Ⅱ级组升高,较Ⅲ级组反有下降趋势。其中仅BNPⅣ级组与Ⅱ级组比较差异有统计学意义(P<0.05)。结论①ADM和BNP有助于不同心功能级别的诊断。②BNP诊断CHF的灵敏度和特异度优于ADM。 Objective To study the plasma levels of adrenomedullin (ADM) and brain natriuretic peptide (BNP) in patients with congestive heart failure (CHF), and compare the clinical value, sensitivity and specificity between the both as diagnostic approaches for CHF. Methods Seventy-two patients with CHF [mean age = (61+16) yrs] were recruited as the study group, comprising 20 cases of survived myocardial infarction or ischemic cardiomyopathy, 16 of hypertension, 18 of valvular incompetence predominant rheumatic heart disease (RHD), and 18 of dilated cardiomy- opathy (DCM). According to functional classification of New York Heart Association (NYHA), these patients included 20 with grade 2 cardiac function, 22 with grade 3 and 30 with grade 4 cardiac function. Based on ejection fraction (EF), 40 patients had an EF 〈40% and 32 had an EF ≥40%. Another 45 non-CHF patients were recruited as controis [mean age = (62+6) yrs], comprising 24 cases of angina pectoris and 21 of hypertension. Of blood samples, plasma ADM levels were determined by radioimmunoassay, and BNP levels were measured with ELISA. All patients received color Doppler echocardiography to determine left ventricular ejection .fraction (LVEF) and left ventricular end-diastolic diameter (LVED). Results Overall, BNP levels in CHF group were markedly higher than those in non-CHF subjects (P〈0.05). ADM levels seemed to be higher in CHF patients, but the difference was of no statistical significance. BNP and ADM levels had significantly negative correlations with LVEF (P〈0.05). BNP levels were independent of etiologies, and demonstrated accurate for diagnosis of CHF with an area under curve (AUC) of receiver operating characteristics (ROC) of 0.82, showing advantages in sensitivity and specificity as compared with ADM (P〈 0.01 ). In relation to NYHA cardiac function grading, levels of ADM and BNP were higher in grade 3 than in grade 2 (both P〈0.05). While ADM (P〉0.05) and BNP (P〈0.05) appeared to be higher in grade 4 than in grade 2, the both tended to be lower in grade 4 compared with grade 3. Conclusion ADM and BNP levels showed benefits in the diagnosis of varied heart functional grading. The sensitivity and specificity of BNP were better than those of ADM.
出处 《中国药物与临床》 CAS 2007年第1期27-30,共4页 Chinese Remedies & Clinics
关键词 心力衰竭 充血性 诊断 肾上腺髓质素 脑钠肽 Heart failure,congestive Diagnosis Adrenomedullin Brain natriuretic peptide
  • 相关文献

参考文献11

  • 1New RB,Sampson AC,King MK,et al.Effects of combined angiotensin Ⅱ and endothelin receptor blockade with developing heart failure:effects on left ventricular performance.Circulation,2000,102(12):1447-1453.
  • 2Maeda K,Tsutamota T,Wada A,et al.Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.Am Heart J,1998,135:825-832.
  • 3Fedak PW,Svetlana M,Altamentova SM,et al.Matrix remodeling in experimental and human heart failure:a possible regulatory role for TIMP-3.Am J Physiol Heart Cire Physiol,2003,284:626-634.
  • 4Field SJ,Tsai FY,Kuo F,et al.E2F-1 Functions in mice to promote apopote apoptosis and suppress proliferation.Cell,1996,85:86.
  • 5Maisel AS,Krishnaswamy P,Nowak RN,et al.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.N Engl J Med,2002,347(3):161-167.
  • 6Suzuki T,Yamaoki K,Nakajima O,et al.Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels.Jpn Heart J,2000,41:205.
  • 7李静宇,王宇航,杨志新.放免法测定血浆脑钠素水平诊断无症状性心力衰竭[J].中国卫生检验杂志,2000,10(4):454-455. 被引量:18
  • 8解丽艳,王晏平,范茜,刘萍,董海.老年人心力衰竭与C-反应蛋白肾上腺髓质素脑钠素和基质金属蛋白酶的关系[J].中华老年医学杂志,2005,24(9):655-658. 被引量:9
  • 9Beinhardt D,Sigusch HH,Hen BE,et al.Cardiac remodeling in end stage heart failure:upregulation of matrix metalloproteinase irrespective of the underlying disease,and evidence for a direct inhibitory effect of ACE inhibitors on MMP.Heart,2002,88:525-530.
  • 10林杰,郑德琳,李庭富.心力衰竭患者血浆脑钠素浓度与心功能的关系[J].临床心血管病杂志,2001,17(10):454-455. 被引量:42

二级参考文献26

  • 1雷秉钧.临床科研设计、衡量与评价 第三讲 病因及因果关系的研究和评价[J].中国实用内科杂志,1994,14(12):750-752. 被引量:5
  • 2[1]Bettencourt P, Ferreira A, Dias P, et al. Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology, 2000,93(1~2): 19-25.
  • 3[2]Mukoyama M, Nakao K, Saito Y, et al. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med, 1990,323: 757-758.
  • 4[3]Raine A E G, Erne P, Burgisser E, et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med, 1986,315: 533-537.
  • 5[4]Yoshimura M, Yasue H, Okumura K, et al. Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation, 1993,87: 464-469.
  • 6[5]Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation, 1994,90: 195-203.
  • 7[6]Hama N, Itoh H, Shirakami G, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation, 1995,92: 1558-1564.
  • 8[7]Arakawa N, Nakamura M, Aoki H, et al. Relati-onship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology, 1994,85:334-340.
  • 9Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med,1999,340:448-454.
  • 10Alonso-Martinez JL,Llorente-Diez B,Echegaray-Agara M, et al. C-reactive protein as a predictor of improvement and readmission in heart failure. Eur J Heart Fail, 2002,49: 331-336.

共引文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部